Clinical Trial: A Study to Evaluate the Safety and Immunogenicity of RSVpreF Coadministered With Herpes Zoster Vaccine in Adults

U.S., March 25 -- ClinicalTrials.gov registry received information related to the study (NCT06890416) titled 'A Study to Evaluate the Safety and Immunogenicity of RSVpreF Coadministered With Herpes Zoster Vaccine in Adults' on March 17.

Brief Summary: This purpose of this phase 3 multicenter, parallel-group, open-label study is to learn about the safety, tolerability, and immunogenicity of RSVpreF and HZ/su vaccine when given together in adults 50 years of age and older.

Study Start Date: April 02

Study Type: INTERVENTIONAL

Condition: Respiratory Syncytial Virus (RSV)

Intervention: BIOLOGICAL: RESPIRATORY SYNCYTIAL VIRUS PREFUSION F SUBUNIT VACCINE

Intramuscular injection

BIOLOGICAL: HZ/su VACCINE

intramuscular injection

Recruitm...